Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Improving the current system for supplying organs for transplantation

R L Horton1, P J Horton

  • 1Lehigh University.

Journal of Health Politics, Policy and Law
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Induction of allogeneic islet tolerance in a large-animal model.

Cell transplantation·2001
Same author

Lack of effect of St John's Wort on carbamazepine pharmacokinetics in healthy volunteers.

Clinical pharmacology and therapeutics·2001
Same author

Ulceration of the urethral meatus after simultaneous pancreas-kidney transplantation.

The Australasian journal of dermatology·2000
Same author

Donor-specific bone marrow and long-term survival of allogeneic arm transplant.

Lancet (London, England)·1999
Same author

Caecal volvulus and malrotation of the bowel complicating the third trimester of pregnancy.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology·1997
Same author

Adduction of the human N-ras codon 61 sequence with (-)-(7S,8R,9R,10S)-7,8-dihydroxy-9,10-epoxy-7,8,9,10-tetrahydrobenzo[a] pyrene: structural refinement of the intercalated SRSR(61,2) (-)-(7S,8R,9S,10R)-N6-[10-(7,8,9,10- tetrahydrobenzo[a]pyrenyl)]-2'-deoxyadenosyl adduct from 1H NMR.

Biochemistry·1996
Same journal

Still Learning from Oregonians About Medicaid.

Journal of health politics, policy and law·2026
Same journal

Communicative Infrastructure and the Global Diffusion of Latin American Food Policy.

Journal of health politics, policy and law·2026
Same journal

Frankenstein or My Fair Lady? Lessons on Participatory Governance from Oregon Medicaid's Priority-Setting Experiment.

Journal of health politics, policy and law·2026
Same journal

How Medicare Advantage Enrollment Affects Spending in Traditional Medicare: Spillovers and Implications for MA Benchmarks.

Journal of health politics, policy and law·2026
Same journal

Abortion Politics: Physician Mobilization in the Wake of the Dobbs Decision.

Journal of health politics, policy and law·2026
Same journal

When Protections Work but Processes Stall: Evaluating the No Surprises Act's Implementation Record.

Journal of health politics, policy and law·2026
See all related articles

The current organ donation system in the US is inadequate. Market systems for organ transplantation are premature; instead, improving the existing voluntary system offers greater potential for increasing organ supply.

Area of Science:

  • Medical Ethics
  • Public Health Policy
  • Transplantation Medicine

Background:

  • The United States relies on a voluntary, altruistic system for organ donation.
  • This system currently yields an inadequate supply of organs for transplantation.
  • Market-based systems have been proposed to address organ shortages.

Purpose of the Study:

  • To evaluate the feasibility and desirability of market systems for organ transplantation.
  • To argue against the immediate implementation of market systems for organs.
  • To propose improvements to the current voluntary organ donation system.

Main Methods:

  • Critical analysis of proposed market systems for organ procurement.
  • Examination of data regarding the potential of the existing voluntary system.
Keywords:
Health Care and Public Health

Related Experiment Videos

  • Development of specific recommendations for enhancing current organ donation practices.

    • Main Results:

    • Market systems for organ transplantation are considered premature and unlikely to be permitted in the US.
    • The current voluntary, altruistic system has significant untapped potential.
    • Specific strategies can be implemented to improve organ supply within the existing framework.

    Conclusions:

    • Market-based organ transplantation systems face substantial legal and ethical barriers in the US.
    • Focusing on optimizing the current voluntary system is a more viable strategy for increasing organ availability.
    • Enhancements to the altruistic system can effectively address the organ shortage.